CAC
CME icon

Core Alternative Capital’s CME Group CME Stock Holding History

Core Alternative Capital’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55M Sell
16,060
-1,819
-10% -$503K 1.06% 39
2026
Q1 		$5.28M Sell
17,879
-1,092
-6% -$324K 1.56% 20
2025
Q4 		$5.18M Sell
18,971
-527
-3% -$143K 1.43% 21
2025
Q3 		$5.27M Sell
19,498
-2,837
-13% -$772K 1.53% 21
2025
Q2 		$6.16M Sell
22,335
-2,482
-10% -$675K 1.68% 17
2025
Q1 		$6.58M Sell
24,817
-5,279
-18% -$1.3M 1.58% 21
2024
Q4 		$6.99M Sell
30,096
-1,205
-4% -$277K 1.46% 26
2024
Q3 		$6.91M Buy
31,301
+1,506
+5% +$312K 1.34% 33
2024
Q2 		$5.86M Sell
29,795
-2,664
-8% -$550K 1.17% 37
2024
Q1 		$6.99M Sell
32,459
-3,037
-9% -$638K 1.25% 37
2023
Q4 		$7.48M Sell
35,496
-6,632
-16% -$1.42M 1.28% 36
2023
Q3 		$8.43M Sell
42,128
-3,934
-9% -$782K 1.3% 37
2023
Q2 		$8.53M Sell
46,062
-6,619
-13% -$1.22M 1.25% 39
2023
Q1 		$10.1M Buy
52,681
+2,134
+4% +$386K 1.35% 40
2022
Q4 		$8.5M Buy
50,547
+2,136
+4% +$371K 1.08% 41
2022
Q3 		$8.57M Buy
48,411
+17,869
+59% +$3.53M 1.37% 41
2022
Q2 		$6.25M Buy
30,542
+6,303
+26% +$1.34M 1.48% 37
2022
Q1 		$5.77M Sell
24,239
-9,091
-27% -$2.14M 1.54% 40
2021
Q4 		$7.01M Sell
33,330
-1,168
-3% -$257K 1.41% 42
2021
Q3 		$6.67M Buy
34,498
+4,018
+13% +$814K 1.4% 45
2021
Q2 		$6.48M Buy
30,480
+4,317
+17% +$911K 1.51% 43
2021
Q1 		$5.34M Buy
26,163
+471
+2% +$92.8K 1.52% 43
2020
Q4 		$4.68M Buy
25,692
+776
+3% +$132K 1.4% 47
2020
Q3 		$4.17M Sell
24,916
-403
-2% -$67.9K 1.42% 47
2020
Q2 		$4.12M Sell
25,319
-3,529
-12% -$633K 1.29% 50
2020
Q1 		$4.99M Buy
28,848
+16,848
+140% +$3.35M 1.75% 23
2019
Q4 		$2.41M Buy
+12,000
New +$2.46M 2.21% 19

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Core Alternative Capital's CME Position: Q2 2026 in Review

Core Alternative Capital reduced its CME Group (CME) stake by 10% in Q2 2026, selling an estimated $503K and leaving 16,060 shares worth $3.55M. The position accounts for 1.06% of the portfolio, ranked #39.

Core Alternative Capital first reported a position in CME in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.1M in Q1 2023. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Core Alternative Capital held 16,060 shares of CME Group worth $3.55M as of Q2 2026.
  • Core Alternative Capital sold 1,819 CME Group shares in Q2 2026, an estimated $503K.
  • CME Group made up 1.06% of Core Alternative Capital's portfolio in Q2 2026, its #39 holding.
  • Core Alternative Capital first reported a position in CME Group in Q4 2019 and has held it in 27 quarters since.
  • Core Alternative Capital's CME Group position peaked at $10.1M in Q1 2023.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.